- Preexposure prophylaxis (PrEP) is independently associated with receipt of primary care (including influenza vaccination, tobacco/depression screenings, glucose testing).
- PrEP use may broaden benefits to include behavioral and mental health, prevention/treatment of comorbid infectious and chronic diseases.
Why this matters
- HIV-infected patients may have greater non-HIV-related care needs, providing PrEP users with additional benefits associated with more opportunities for non-HIV-related screenings.
- Primary care practitioners should make an effort to offer PrEP to eligible patients with HIV.
- 5857 HIV-uninfected individuals tested for rectal sexually transmitted infections.
- 35% (2047/5857) were prescribed PrEP.
- Overall, 40% (2357) participants had influenza vaccination, 74% (4352) tobacco screening, 72% (4211) depression screening, 51% (2984) glucose testing, 15% (894) HbA1c testing.
- Compared with nonusers, higher proportion of PrEP users received influenza vaccination (adjusted prevalence ratio [aPR], 1.28; 98% CI, 1.20-1.37), tobacco screening (aPR, 1.06; 95% CI, 1.02-1.09), depression screening (aPR, 1.07; 95% CI, 1.04-1.11), and glucose testing (aPR, 1.78; 95% CI, 1.69-1.88).
- Cross-sectional analysis comparing the proportion of PrEP users and nonusers receiving primary care.
- Funding: National Institutes of Allergy and Infectious Diseases, National Institute of Mental Health.
- Cross-sectional design precludes conclusion causality, temporality.
- Possibly nongeneralizable to community health centers with other missions.